Home › NDC Lookup › RxCUI directory › RxCUI 2727218

300 ML vancomycin 5 MG/ML Injection [Tyzavan] — RxCUI 2727218

Name: 300 ML vancomycin 5 MG/ML Injection [Tyzavan] (RxCUI 2727218)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic branded drug

RxCUI 2727218 Semantic branded drug · SBD ● Current RxNorm concept 7 FDA products 10 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2727218

Official name300 ML vancomycin 5 MG/ML Injection [Tyzavan]

Concept typeSemantic branded drug (SBD)

RxNorm statusCurrent RxNorm concept

Also known as300 ML Tyzavan 5 MG/ML Injection; TYZAVAN 1.5 GM in 300 ML Injection; Tyzavan 1.5 GM per 300 ML Injection

FDA products mapped7

Package NDCs mapped10

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Vancomycin Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

When vancomycin is given by IV, it gets directly into your bloodstream and reaches infections in your blood, heart, bones, lungs, or skin. When it's swallowed, it mostly stays in y...
Why am I getting vancomycin by IV instead of taking a pill?
The most common thing people notice is flushing, redness, or itching on the face, neck, and upper chest — especially if the infusion runs too fast. This is sometimes called 'Red Ma...
What should I watch for during my vancomycin infusion?

📖 Read our full Vancomycin Injection guide →

🕸️ Concept Web — How 300 ML vancomycin 5 MG/ML Injection [Tyzavan] Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept 300 ML vancomycin 5 MG/ML Injection [Tyzavan] RxCUI 2727218 Semantic branded drug · SBD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 1

The active substance itself — no strength, form, or brand attached yet.
- Vancomycin 11124 IN
Brand names 1

The same medicine's trade names. A brand name alone says nothing about strength or form.
- Tyzavan 2725131 BN
Dose forms 6

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Vancomycin Injection 1807507 SCDF
- Vancomycin Injectable Product 1160499 SCDG
- Vancomycin Injection [Tyzavan] 2725134 SBDF
- Tyzavan Injectable Product 2725133 SBDG
- Injection 1649574 DF
- Injectable Product 1151126 DFG
Clinical & branded drugs 3

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- 300 ML vancomycin 5 MG/ML Injection 2118448 SCD
- Vancomycin 5 MG/ML 330528 SCDC
- Vancomycin 5 MG/ML [Tyzavan] 2725132 SBDC

Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

300 ML vancomycin 5 MG/ML Injection SCD · 2118448
Vancomycin 5 MG/ML SCDC · 330528
Vancomycin Injection SCDF · 1807507
Vancomycin Injectable Product SCDG · 1160499

Brand-Name Concepts

Vancomycin 5 MG/ML [Tyzavan] SBDC · 2725132
Vancomycin Injection [Tyzavan] SBDF · 2725134
Tyzavan Injectable Product SBDG · 2725133
Tyzavan BN · 2725131

📦 FDA Products & Package NDCs

7 products · 10 package NDCs

10 package NDCs map to RxCUI 2727218 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
00143-9466-06	6 BAG in 1 CARTON (0143-9466-06) / 250 mL in 1 BAG (0143-94...	TYZAVAN	Hikma Pharmaceuticals USA Inc.	2025-10-17
00143-9467-06	6 BAG in 1 CARTON (0143-9467-06) / 350 mL in 1 BAG (0143-94...	TYZAVAN	Hikma Pharmaceuticals USA Inc.	2025-10-17
00143-9468-06	6 BAG in 1 CARTON (0143-9468-06) / 150 mL in 1 BAG (0143-94...	TYZAVAN	Hikma Pharmaceuticals USA Inc.	2025-10-17
00143-9468-12	12 BAG in 1 CARTON (0143-9468-12) / 150 mL in 1 BAG (0143-9...	TYZAVAN	Hikma Pharmaceuticals USA Inc.	2025-10-17
00143-9469-06	6 BAG in 1 CARTON (0143-9469-06) / 300 mL in 1 BAG (0143-94...	TYZAVAN	Hikma Pharmaceuticals USA Inc.	2025-10-17
00143-9470-06	6 BAG in 1 CARTON (0143-9470-06) / 400 mL in 1 BAG (0143-94...	TYZAVAN	Hikma Pharmaceuticals USA Inc.	2025-10-17
00143-9471-06	6 BAG in 1 CARTON (0143-9471-06) / 100 mL in 1 BAG (0143-94...	TYZAVAN	Hikma Pharmaceuticals USA Inc.	2025-10-17
00143-9471-12	12 BAG in 1 CARTON (0143-9471-12) / 100 mL in 1 BAG (0143-9...	TYZAVAN	Hikma Pharmaceuticals USA Inc.	2025-10-17
00143-9472-06	6 BAG in 1 CARTON (0143-9472-06) / 200 mL in 1 BAG (0143-94...	TYZAVAN	Hikma Pharmaceuticals USA Inc.	2025-10-17
00143-9472-12	12 BAG in 1 CARTON (0143-9472-12) / 200 mL in 1 BAG (0143-9...	TYZAVAN	Hikma Pharmaceuticals USA Inc.	2025-10-17

Observed labelers: Hikma Pharmaceuticals USA Inc. (10) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.

Code	Descriptor	Mapped packages	Sources
J3375	Inj vancomycin (xellia) 10mg	7	CMS

⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.